Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro

Cited by (113)

Items 101–113 of 113

1. Modeling Urothelial Carcinoma and Immunotherapy Response Using Organoid Platforms: From Epithelial Tumor Organoids to Multilineage Systems
   Jorge O. Múnera · 2026 · Cancers
2. The place of three-dimensional cell technologies in urology and urologic oncology
   Vardikian A.G. Vardikian, Svetlana Piatnitskaia, Насибуллин Ильдар Марсович, A. I. Rakhmatullina, В. Н. Павлов · 2026 · Kazan medical journal
3. Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC
   Gabriella Antignani, Michaela Feodoroff, Jacopo Chiaro, Sara Feola, Salvatore Russo, Firas Hamdan, Manlio Fusciello, Federica D’Alessio, Paolo Bottega, Yvonne Giannoula et al. · 2026 · Molecular Therapy Oncology
4. Next-generation of mesothelin-targeted CAR-T cells secreting anti-PD-L1 scFv for potent immunotherapy against 3D patient-derived colorectal cancer organoids
   Nattaporn Phanthaphol, Pattara Kanoksing, Woramin Riansuwan, Siriluck Prapasrivorakul, Pornraksa Ovartchaiyapong, Aitsariya Mongkhonsupphawan, Surat Phumphuang, Mutita Junking, Peti Thuwajit, Pa‐thai Yenchitsomanus et al. · 2026 · BMC Medicine
5. Bladder cancer organoids in precision medicine: bridging basic science, clinical therapeutics and drug development
   钟雪松, Gang Wang, H R Zhang, Yongjing Shi, Zeyi Xiong, Jian Han · 2026 · Cancer Cell International
6. Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancreatic cancer organoids
   Xu Wang, Ruijie Wang, Xuan Lin, Xuan Zou, Yusheng Chen, Mingjian Ma, Mengxing Pan, Jinxin Chen, Yu Yan, Fei Ding et al. · 2026 · Pancreatology
7. Organoid Coculture Models for Cancer Research and Immunotherapy
   Zhuo Yang, Huihui Yang, LI Guangxin, Guobang Liu, Zhulan Chen, Wenzhi Tian, Meiyang Huang, Xiaoling Liu, Yongsheng Zhao, Dong Chen · 2026 · Med Research
8. Patient-derived tumor organoid co-culture systems as translational platforms for cancer immunotherapy and precision oncology
   Mohamed Gadelkarim, Ahmed Elsayed, Tasneem Abaza, Ahmed Reda Bahr, Yousif Abou-Elwan Elsayed, Omer Iqbal · 2026 · Clinical Cancer Bulletin
9. Building Fit-for-Purpose, Multi-Lineage Immune–Organoid Models for Urologic Cancers: A Critical Narrative Review of Prostate, Urothelial and Renal Cell Carcinoma Models
   Emmanuel Ojeabuo Oisakede, Okhibhamen Ehizokhale, Olawunmi O. Oyedeji, David B. Olawade · 2026 · Organoids
10. Modeling inflammation and inflammatory diseases in organoids
    Amber De Moor, Hugo E J Vankelecom, Kaline Arnauts · 2026 · British Medical Bulletin
11. Organoids in drug discovery and development: emerging technologies to transition beyond animal models
    Jolene Phelps, Amanda Orr, Stephanie Michelle Willerth · 2026 · Expert Opinion on Drug Discovery
12. Antigen persistence after antibody-drug conjugates in urothelial carcinoma: implications for CAR-cell target selection
    Jiayi Liu, Shaoqiang Xing, Qian Liu · 2026 · Neoplasia
13. Evidence gaps and route-dependent development requirements for CAR cellular therapy in urothelial carcinoma: a systematic evidence map and public-data analysis
    Jiayi Liu, Zhibiao Guo, Jinke Guo, Shaoqiang Xing, Qian Liu · 2026 · Frontiers in Immunology